- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1144
0 new
Companies which are more than 50% undervalued based on analyst price target.
1,144 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PDD | US$100.07 | -12.2% | -15.7% | US$139.0b | US$151.49 | PE9.3x | E14.2% | n/a | Retail | ||
BIIB | US$157.90 | -1.3% | -31.9% | US$23.0b | US$251.70 | PE14.2x | E12.4% | n/a | Pharmaceuticals & Biotech | ||
MRNA | US$41.11 | 11.6% | -47.6% | US$15.8b | US$77.55 | PS3.1x | E17.9% | n/a | Pharmaceuticals & Biotech | ||
RPRX | US$26.43 | 2.8% | -2.3% | US$15.6b | US$41.53 | PE10.3x | E6.3% | 3.2% | Pharmaceuticals & Biotech | ||
SMMT | US$19.00 | 3.8% | 850.0% | US$14.0b | US$34.27 | PB32x | S85.4% | n/a | Pharmaceuticals & Biotech | ||
BMRN | US$64.26 | 1.3% | -27.1% | US$12.2b | US$98.39 | PE38x | E27.3% | n/a | Pharmaceuticals & Biotech | ||
PCVX | US$88.54 | 2.0% | 79.5% | US$11.0b | US$151.75 | PB3.2x | E-4.5% | n/a | Pharmaceuticals & Biotech | ||
SRPT | US$114.23 | 9.3% | 37.8% | US$10.9b | US$189.62 | PE89.5x | E42.6% | n/a | Pharmaceuticals & Biotech | ||
EDU | US$57.36 | 2.6% | -23.9% | US$9.4b | US$86.24 | PE24.1x | E20.7% | 1.0% | Consumer Services | ||
AES | US$13.04 | -6.7% | -23.0% | US$9.3b | US$21.21 | PE9x | E13.8% | 5.3% | Utilities | ||
VFS | US$3.93 | -2.0% | -40.1% | US$9.2b | US$6.33 | PS7x | E-4.9% | n/a | Automobiles | ||
ONTO | US$166.29 | 4.9% | 20.9% | US$8.2b | US$255.12 | PE44.8x | E30.7% | n/a | Semiconductors | ||
LEGN | US$40.94 | 7.2% | -32.3% | US$7.5b | US$82.55 | PS14.4x | E70.5% | n/a | Pharmaceuticals & Biotech | ||
WFRD | US$85.83 | 4.8% | -8.3% | US$6.2b | US$130.00 | PE11.7x | E5.2% | 1.2% | Energy | ||
LKNC.Y | US$22.05 | -3.1% | -35.0% | US$6.2b | US$34.10 | PE18.8x | E25.5% | n/a | Consumer Services | ||
VKTX | US$52.59 | 6.1% | 328.3% | US$5.9b | US$112.57 | PB6.4x | E-1.8% | n/a | Pharmaceuticals & Biotech | ||
CYTK | US$49.10 | -2.2% | 53.6% | US$5.8b | US$81.41 | PS1800.1x | E36.7% | n/a | Pharmaceuticals & Biotech | ||
IONS | US$34.01 | -1.0% | -31.7% | US$5.4b | US$61.36 | PS6.7x | E32.9% | n/a | Pharmaceuticals & Biotech | ||
ZETA | US$22.38 | 27.3% | 158.1% | US$5.3b | US$38.42 | PS5.9x | E123.5% | n/a | Software | ||
RNA | US$43.25 | 2.5% | 590.9% | US$5.2b | US$68.55 | PS510x | E32.4% | n/a | Pharmaceuticals & Biotech | ||
LBTY.A | US$13.32 | 9.0% | -17.7% | US$4.8b | US$23.38 | PS0.6x | E53.3% | 75.5% | Telecom | ||
BBIO | US$23.42 | -1.3% | -20.8% | US$4.4b | US$46.89 | PS20.3x | E30.8% | n/a | Pharmaceuticals & Biotech | ||
MMS | US$73.09 | -7.7% | -12.7% | US$4.4b | US$114.00 | PE14.4x | E1.0% | 1.6% | Commercial Services | ||
RARE | US$47.24 | 5.6% | 20.7% | US$4.4b | US$92.43 | PS8.3x | E54.2% | n/a | Pharmaceuticals & Biotech |